OPKO Health settles DOJ investigation for $10M; admits improper physician payments

OPKO HEALTH, INC.

Settlement resolves False Claims Act allegations; total payment $10M plus 1.5% annual interest from Sep 2021.
Admits BioReference paid above-fair-market rent to physician groups from Jan 2013 to Mar 2021.
OPKO and BioReference entered a 5-year Corporate Integrity Agreement with enhanced compliance obligations.
Annual meeting approved all 13 director nominees, say-on-pay, and equity plan increase to 60M shares.
Ernst & Young ratified as independent auditor for FY 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.